SAC Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-140,522	Closed	-$9.44M	–	50
2014 Q1	$9.44M	Buy	140,522 +95,087	+209%	+$6.38M	0.05%	383
2013 Q4	$2.92M	Sell	45,435 -19,565	-30%	-$1.26M	0.02%	558
2013 Q3	$4.16M	Sell	65,000 -555,449	-90%	-$35.6M	0.02%	506
2013 Q2	$19.2M	Buy	+620,449	New	+$19.2M	0.11%	232